Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress KTCC Q1 2026 Earnings Negative EPS Highlights Ongoing Operational Challenges CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline VMD Q1 2026 Earnings EPS Misses Estimates by 34 Amid Uncertain Revenue Outlook Norfolk Southern Q1 2026 Earnings EPS Beat Lifts Shares Despite Macro Headwinds RDVT Q1 2026 Earnings Earnings Beat Estimates by Over 40 Stock Rises